Atlas Trials

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Clinical trial NCT01377896 · COMPLETED

Trial details

NCT number
NCT01377896
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
SchizophreniaBipolar DisordersMajor Depressive Disorders
Start date
2010-07-01
Primary completion
2010-10-01
Enrollment
221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.